Michael Engsig

Michael EngsigMichael Engsig
ME

Michael Engsig

CEO

Rate

About

Michael Engsig is a pharmaceutical professional with extensive biotech and pharma experience, currently serving as the CEO of Nykode Therapeutics. He has held specialist and managerial roles at Takeda and Nycomed, and joined Nykode Therapeutics in 2017. He holds a civil engineering (MSc) degree in chemistry specializing in biotechnology from the Technical University of Denmark, and a Graduate Diploma in Business Administration (HD) in organization and leadership from the Copenhagen Business School (CBS).
Frequently asked

Who is Michael Engsig?

Michael Engsig is a pharmaceutical professional with extensive biotech and pharma experience, currently serving as the CEO of Nykode Therapeutics. He has held specialist and managerial roles at Takeda and Nycomed, and joined Nykode Therapeutics in 2017. He holds a civil engineering (MSc) degree in chemistry specializing in biotechnology from the Technical University of Denmark, and a Graduate Dipl…

What is Michael Engsig's current role?

Michael Engsig is currently CEO.

Comments

No comments yet. Be the first to share your take.

Profile

About Michael Engsig

Michael Engsig is CEO. This profile tracks their companies, funding activity, and news mentions across the AI ecosystem.